Paxlovid
An innovative project for direct access to real-time, real-world data
In 2022, Accessa initiated the Paxlovid pilot project to collect in real-time, real-context structured data with the new treatment for Covid-19, to answer a need expressed by the Institut national d’excellence en santé (INESSS). We invite you to read our publication Direct access to real-time, real-world data and discover how the project was initiated, developed, and the conclusive results that were generated, opening unlimited possibilities.